荃銀高科(300087.SZ):收到控股子公司歸還逾期財務資助
格隆匯7月20日丨荃銀高科(300087.SZ)公佈,此前披露,為支持控股子公司安徽荃銀高科農業投資開發有限公司(“荃銀農投”,公司持股比例為51%)發展,經公司2020年4月3日第四屆董事會第十五次會議審議通過,公司向荃銀農投提供財務資助不超過人民幣8000萬元,期限不超過1年(自2020年6月1日至2021年5月31日),借款利率在銀行同期貸款利率的基礎上增加1%。截至2021年5月31日,荃銀農投有2600萬元本金逾期。
截至公吿披露日,荃銀農投累計償還本息共計8266.75萬元,本金及利息均已還清。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.